Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Reviews in Cardiovascular Medicine|January 25, 2005
Drug-eluting stents for emerging treatment strategies in complex lesionsCharles A Simonton, Bruce R Brodie, B Hadley Wilson
ISRN Cardiology|July 18, 2013
Risk factors for coronary drug-eluting stent thrombosis: influence of procedural, patient, lesion, and stent related factors and dual antiplatelet therapyKrishnankutty Sudhir, James B Hermiller, Joanne M Ferguson, et al.
Coronary Artery Disease|August 26, 2016
Bioresorbable vascular scaffolds for the treatment of coronary artery disease: what have we learned from randomized-controlled clinical trials?David G Rizik, James B Hermiller, Charles A Simonton, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 15, 2013
An evidence-based review of the impact of periprocedural myocardial infarction in carotid revascularizationErik Stilp, Colleen Baird, William A Gray, et al.
Cardiovascular Intervention and Therapeutics|October 9, 2015
Feasibility of 320-row multi-detector computed tomography angiography to assess bioabsorbable everolimus-eluting vascular scaffoldsMasahiko Asami, Jiro Aoki, Patrick W Serruys, et al.
The Journal of Invasive Cardiology|August 3, 2006
AngioJet experience from the multi-center STENT RegistryCharles A Simonton, Bruce R Brodie, Hadley Wilson, et al.
Journal of the American College of Cardiology|September 25, 2007
Comparative clinical outcomes of paclitaxel- and sirolimus-eluting stents: results from a large prospective multicenter registry--STENT GroupCharles A Simonton, Bruce Brodie, Barrett Cheek, et al.
American Heart Journal|September 29, 2009
SPIRIT IV trial design: a large-scale randomized comparison of everolimus-eluting stents and paclitaxel-eluting stents in patients with coronary artery diseaseEugenia Nikolsky, Alexandra J Lansky, Krishnankutty Sudhir, et al.
The American Journal of Cardiology|June 2, 2012
Cost-effectiveness of everolimus- versus paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization (from the SPIRIT-IV Trial)Amit P Amin, Matthew R Reynolds, Yang Lei, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 1, 2020
Long-term outcomes of percutaneous coronary intervention for in-stent restenosis among Medicare beneficiariesHector Tamez, Eric A Secemsky, Linda R Valsdottir, et al.
Pageof 5